Fellowship · Philadelphia, PA
Sponsored by Temple University Hospital
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Leukemia · 2022 · 3,530 citations · Reza Nejati
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 188 citations · Reza Nejati
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 265 citations · Reza Nejati
Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2024 · 45 citations · Reza Nejati
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.
Haematologica · 2021 · 48 citations · Mariusz Wasik
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
Haematologica · 2021 · 45 citations ·
Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication.
Blood cancer journal · 2021 · 44 citations · Reza Nejati, Mariusz Wasik
B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP Workshop.
American journal of clinical pathology · 2023 · 18 citations · Reza Nejati, Mariusz Wasik